PHEAST THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 19 May 2025)
What this means for you
Not registered yet, but its 04 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97295204
- Mark type
- Stylized text
- Filed
- 04 Mar 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical and biological research services; research and development of pharmaceuticals for the treatment of cancer; medical testing services and information in the field of cancer research
Owner
- Pheast Therapeutics, Inc., Redwood City, CA, US
- Pheast Therapeutics, Inc., Palo Alto, CA, US
Prosecution history
- 21 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 20 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2025 — SOU EXTENSION 4 GRANTED
- 19 May 2025 — SOU EXTENSION 4 FILED
- 19 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Nov 2024 — SOU EXTENSION 3 GRANTED
- 26 Nov 2024 — SOU EXTENSION 3 FILED
- 26 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 24 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2024 — SOU EXTENSION 2 GRANTED
- 23 May 2024 — SOU EXTENSION 2 FILED